A
Agtclabs
agtclabs.com
Website unreachable since Oct 17, 2026
AGTC develops a Gene Transfer Device utilizing non-viral, carbon nanotube-mediated gene transfer for cell therapy manufacturing. This technology addresses limitations in current methods by enabling the inexpensive and scalable production of cell therapies. The company's focus is on removing barriers to accelerate innovation and broaden access to life-saving cell treatments.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- AGTC develops a Gene Transfer Device utilizing non-viral, carbon nanotube-mediated gene transfer for cell therapy manufacturing. This technology addresses limitations in current methods by enabling the inexpensive and scalable production of cell therapies. The company's focus is on removing barriers to accelerate innovation and broaden access to life-saving cell treatments.